Product Information
BUPRENORPHINE 7.5 MCG/HR PATCH is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $37.8502 per EA under NDC 69238150502. Its NADAC has been published 309 times since Sep 23, 2020.
FDA first approved this application on Apr 14, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 ug/h
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238150502
Classification
Generic
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Effective Date
8/19/2026
Active Ingredients
BUPRENORPHINEApproval Type
Generic (ANDA)
FDA Application
ANDA211586FDA Approved
4/14/2020
TE Code
AB
On Market Since
4/20/2020
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE 7.5 MCG/HR PATCH has been published 309 times since Sep 23, 2020, and over the history we have for it it has declined 34.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $37.8502 per EA |
|---|---|
| All-time high | $71.9815 (Nov 10, 2021) |
| All-time low | $25.3493 (Nov 20, 2024) |
| 52-week high | $37.8502 |
| 52-week low | $30.1197 |
| Median price | $46.6866 |
| Average price | $45.9164 |
| Largest weekly change | +34.4% (Dec 21, 2022) |
| Weeks tracked | 309 |
| Tracking since | Sep 23, 2020 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUPRENORPHINE 7.5 MCG/HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE 7.5 MCG/HR PATCH, manufactured by Amneal Pharmaceuticals NY LLC, is $37.8502 per EA (NDC 69238150502), effective Aug 19, 2026.
How has the price of BUPRENORPHINE 7.5 MCG/HR PATCH changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE 7.5 MCG/HR PATCH has declined 34.9%. It has been tracked across 309 weekly CMS publications since Sep 23, 2020.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE 7.5 MCG/HR PATCH?
Since Sep 23, 2020, the NADAC for BUPRENORPHINE 7.5 MCG/HR PATCH has ranged from a low of $25.3493 (Nov 20, 2024) to a high of $71.9815 (Nov 10, 2021), with a median of $46.6866 per EA.
Are there cheaper alternatives to BUPRENORPHINE 7.5 MCG/HR PATCH?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPRENORPHINE 7.5 MCG/HR PATCH in a comparable dosage form, but none are currently priced below it.
Who manufactures BUPRENORPHINE 7.5 MCG/HR PATCH?
BUPRENORPHINE 7.5 MCG/HR PATCH (NDC 69238150502) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.